UBS analyst Colin Bristow maintains Biogen (NASDAQ:BIIB) with a Buy and raises the price target from $238 to $309.
Sidus Space Enters Pivotal Year Building On A Strong Foundation Of Achievements In 2022
Sidus Space, Inc. (NASDAQ:SIDU), a Space-as-a-Service company focused on mission-critical hardware manufacturing combined with commercial satellite design, manufacture, launch, and data collection, is pleased to release
